IVA
Inventiva S.A.
NASDAQ · Healthcare · Biotechnology · FR
$4.78
−1.24%Margins
Gross margin
78.8%
EBITDA margin
-2997.7%
EBIT margin
-1670.3%
Net margin
-3925.4%
FCF margin
-1422.9%
1849.6%
Return on equity
-215.8%
Return on assets
-752.6%
Return on invested capital
0.06x
Asset turnover
-$225.6M
Cash from operations
$0.49
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025